The Drug-Induced Respiratory Disease Website
Philippe Camus, M.D.
Browse by »
Valvular heart disease and/or dysfunction
Last update :
Drug and radiation history
Drug singularity - Correct identification of the drug
Consistent timing of exposure v. onset of symptoms
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
Careful exlusion of another cause
Remission of symptoms with removal of drug
Recurrence with rechallenge (rarely advisable)
More detailed checklist
See also under
Ergots, ergot alkaloids, ergolines
Cardiac valve disease and low-dose dopamine agonist therapy: an artefact of reporting bias?
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
Fibrotic valvular heart disease subsequent to bromocriptine treatment.